The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence

Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders

Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,676

Memantine in Moderate-to-Severe Alzheimer's Disease

Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043

beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity

Mattson, M. P., Cheng, B., Davis, D. G., Bryant, K., Lieberburg, I. M., & Rydel, R. E. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00376.1992 · Cited by 1,633

The Time Course of Glutamate in the Synaptic Cleft

Clements, J. D., Lester, R. A. J., Tong, G., Jahr, C. E., & Westbrook, G. L. (1992) · Science · doi:10.1126/science.1359647 · Cited by 1,089

Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease.

Pearson, R. C., Esiri, M. M., Hiorns, R. W., Wilcock, G. K., & Powell, T. P. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.13.4531 · Cited by 987

Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical data

Parsons, C. G., Danysz, W., & Quack, G. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00019-2 · Cited by 900

Staging of Alzheimer-Related Cortical Destruction

Braak, H., Braak, E., & Bohl, J. (2008) · European Neurology · doi:10.1159/000116984 · Cited by 836 · cited 2×

Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain

Moechars, D., Dewachter, I., Lorent, K., Reversé, D., Baekelandt, V., Naidu, A., Tesseur, I., Spittaels, K., Haute, C. V. D., Checler, F., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6483 · Cited by 668

β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage

Koh, J., Yang, L. L., & Cotman, C. W. (1990) · Brain Research · doi:10.1016/0006-8993(90)91355-k · Cited by 617

Alternative excitotoxic hypotheses

Albin, R. L., & Greenamyre, J. T. (1992) · Neurology · doi:10.1212/wnl.42.4.733 · Cited by 574 · cited 1×

Glutamate theory in developing novel pharmacotherapies for obsessive compulsive disorder: Focusing on N-methyl-D-aspartate signaling

Wu, P.-L., Lane, H., Tang, H., & Tsai, G. E. (2012) · Biomedicine · doi:10.1016/j.biomed.2012.04.003 · Cited by 4

Memantine: A Treatment for Alzheimer’s Disease with a New Formulation

Makino, K. M., & Porsteinsson, A. P. (2011) · Aging Health · doi:10.2217/ahe.11.31 · Cited by 4

Canin vitroassessment provide relevant end points for cognitive drug programs?

Albensi, B. C. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460440802580700 · Cited by 3

Cognitive-Enhancing Substances and the Developing Brain: Risks and Benefits

Urban, K. R., & Gao, W. (2021) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-54564-2_29 · Cited by 2

Evaluation and Comparison of Fullerene (C60) Aqueous Suspension Administration Effects with Memantine HCL in Rat Model of Alzheimer’s Disease Considering Behavioral Patterns and Spatial Memory

Andalib, S., Nikpour, M., Hamidi, M., Javadi, R., & Mohamadpour, H. (2024) · Journal of Microbiota · doi:10.5812/jmb-143061 · Cited by 3

Multifaceted roles of mammalian heat shock factor 1 in the central nervous system

Rozema, N. B., & Gómez‐Pastor, R. (2025) · Cell Stress and Chaperones · doi:10.1016/j.cstres.2025.100109 · Cited by 5

Alzheimer Hastalığı ve Anti-Alzheimer Etkili Bileşiklerin Yapılarının Araştırılması

Tari, O., & YAĞMURTAŞAN, R. (2023) · Hacettepe University Journal of the Faculty of Pharmacy · doi:10.52794/hujpharm.1175099 · Cited by 3

An update on pathological implications of enzymatic dysregulation in Alzheimer's disease

Choudhury, A., Chakraborty, I., Bhattacharjee, R., Banerjee, T. S., Vana, D. R., Adapa, D., & Bhardwaj, R. (2018) · Biomedical Research - India · doi:10.4066/biomedicalresearch.29-18-767 · Cited by 3

Critical Review on the Relationship between Glaucoma and Alzheimer's Disease

Rusciano, D. (2014) · Advances in Ophthalmology & Visual System · doi:10.15406/aovs.2014.01.00024 · Cited by 5

Nanomedicine Based Drug Targeting in Alzheimer’s Disease: High Impact of Small Carter

Ahmad, M. Z., Akhter, S., Rahman, Z., Ahmad, J., Ahmad, I., & Ahmad, F. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-803959-5.50016-7 · Cited by 3

Coadministration of Memantine with Acetylcholinesterase Inhibitors

Dekundy, A. (2006) · Elsevier eBooks · doi:10.1016/b978-012088523-7/50005-3 · Cited by 3

Cognitive Disorders: Impairment, Aging, and Dementia

van Goethem, N. P., Lardenoije, R., Kompotis, K., Rutten, B. P. F., Prickaerts, J., & Steinbusch, H. W. M. (2014) · Methods and principles in medicinal chemistry · doi:10.1002/9783527679348.ch16 · Cited by 3

Overlap in synaptic neurological condition susceptibility pathways and the neural pannexin 1 interactome revealed by bioinformatics analysesPreprint

Frederiksen, S., Wicki‐Stordeur, L. E., & Swayne, L. A. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/801563 · Cited by 3

Implication du système cholinergique dans l'altération de la mémoire de travail au cours du vieillissement chez la souris : approche comportementale, pharmacologique et neurofonctionnelle

Vandesquille, M. (2011) · theses.fr (ABES) · doi:10.70675/ad96bd3dz8a44z499czbeacz7a1e24572e30 · Cited by 2

Natural Products Targeting Alzheimer’s Disease via NF-κB Pathway: A Review

Hasan, F., Thippamma, K., Kumar, V., Baiseitova, A., Ikram, M. A., & Shah, A. B. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273397045250922054643 · Cited by 2

Targeting of kinases to treat neurodegenerative diseases

Shomali, T., & Trempe, J.-F. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100128 · Cited by 4

Clinical trials for Alzheimer's disease in Down syndrome

Rafii, M. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818845-3.00017-7 · Cited by 2

Epigenetic regulons in Alzheimer's disease

Raval, M., Mishra, S., & Tiwari, A. K. (2023) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.01.012 · Cited by 2

Potential Neuroprotective Strategies using Smart Drug Delivery Systems for Alzheimer’s Disease

Khan, J., Yadav, S., & Alam, A. (2023) · Infectious Disorders - Drug Targets · doi:10.2174/0118715265254985231012065058 · Cited by 2

Pharmacogenomics of Neurodegenerative Diseases: Roles in Personalized Medicines

Gupta, A. K., Evande, R. E., Dutta, R., Tan, C., & Mahato, R. I. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_34 · Cited by 2

Therapeutic Potential of products derived from Pluchea lanceolata for Alzheimer’s Disease Treatment

Syed, A., Elgorban, A. M., Bahkali, A. H., Wang, S., Wong, L. S., Dhara, B., Uti, D. E., Alum, E. U., & Atangwho, I. J. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02409-5 · Cited by 2

N-Methyl-D-Aspartate Receptors Mediate Excitotoxicity in Amyloid Beta-Induced Synaptic Pathology of Alzheimer’s Disease

Liu, J., Gao, X., & Wu, Y. (2008) · Neuroembryology and Aging · doi:10.1159/000193851 · Cited by 2

Ca2+ Inhibits the Association of Memantine with N-Methyl-D-aspartate (NMDA) Receptor-Gated Ion Channels

Fujimoto, M., Iida, H., Homma, T., Kimura, I., Mori, M., & Hamana, H. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.1813 · Cited by 2

Effects of Memantine on Latent Inhibition of Active Avoidance in Wistar Rats

Лоскутова, Л. В., & Kostyunina, N. V. (2009) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-009-0605-0 · Cited by 2

Effects of NMDA Receptors in Synapses and Extrasynapses of Rat Hippocampal Neurons on Amyloid-Beta-Induced Alterations in PSD-95 Expression

Liu, J., Wu, Y., Chang, L., Peng, J., Song, Y., Lu, T., & Gao, X. (2008) · Neuroembryology and Aging · doi:10.1159/000183034 · Cited by 2

Patch Clamp Combined with Voltage/Concentration Clamp to Determine the Kinetics and Voltage Dependency of N-Methyl-d-aspartate (NMDA) Receptor Open Channel Blockers

Parsons, C. G., & Gilling, K. E. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1096-0_3 · Cited by 2

Alzheimer’s Disease: Focus on the Neuroprotective Role of Melatonin

Srinivasan (2012) · Journal of Neurology Research · doi:10.4021/jnr93w · Cited by 6

A Brief Review of Alzheimer’s Disease

Yavari, M. D. (2021) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2021.35.005747 · Cited by 2

Memantine: the next trend in academic performance enhancement?

Ota, K. S., & Godwin, T. (2006) · PubMed · Cited by 2

Resilience Activity of Glycyrrhiza glabra in Relation to Cancer: Chemistry and Mechanism

Dhingra, N., Sharma, S., Kumari, P., & Kar, A. (2023) · Springer eBooks · doi:10.1007/978-3-031-28780-0_20 · Cited by 1

Dizocilpine derivatives as neuroprotective NMDA receptor antagonists without psychomimetic side effects

Konecny, J., Misiachna, A., Chvojková, M., Kletečková, L., Kolcheva, M., Novak, M., Prchal, L., Ladislav, M., Hemelíková, K., Netolický, J., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116981 · Cited by 1

Immunotherapy of Alzheimer’s Disease

Tondo, G., Marchi, F. D., Anselmi, M., & Comi, C. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_51 · Cited by 1

Memory reconsolidation impairment by amyloid beta (1–42) and its prevention by non-competitive antagonists of NMDA receptors

Тиунова, А. А., Diffine, E. A., & Anokhin, K. V. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1629492 · Cited by 1

Effects of different physical activity interventions on executive function in older adults with dementia: a systematic review and network meta-analysis

Zhu, Y., Li, S., Xiao, Z., Wang, H., Zhang, X., Huang, Q., Yin, R., Guo, K., & Li, D. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1643957 · Cited by 2

A comprehensive exploration of the structure–activity relationships, multitarget strategies, and therapeutic mechanisms of triazole scaffolds in Alzheimer’s disease

Malvankar, A., Raut, M., Singh, S. K., Singh, R., Mahindroo, N., & Bajad, N. G. (2026) · Future Medicinal Chemistry · doi:10.1080/17568919.2026.2684615 · Cited by 1

Critical appraisal and role of memantine extended-release in the management of Alzheimer’s disease

Singh, I., & Grossberg, G. T. (2011) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s14410 · Cited by 1

Quantitative determination of memantine in human plasma by GC using negative ion chemical ionization MS detection after derivatization with a new reagent, o-(pentafluorobenzyloxycarbonyl)-2,3,4,5-tetrafluorobenzoyl chloride

Leis, H. J., & Windischhofer, W. (2012) · Microchimica Acta · doi:10.1007/s00604-012-0886-2 · Cited by 1

Bis(12)-Hupyridone, a Promising Multi-Functional Anti-Alzheimer’s Dimer Derived from Chinese Medicine

Cui, W., Choi, T. C., Mak, S., Yu, H., Hu, S., Li, W., Zuo, Z., & Yifan, H. (2012) · InTech eBooks · doi:10.5772/35663

Anti-dementia Medication

Jelić, V., & Winblad, B. G. (2021) · Springer eBooks · doi:10.1007/978-3-030-77904-7_5 · Cited by 1

Pharmacological Management of Dementia—An Overview

Dikshit, R., Karia, S., Thakurdesai, A., Merchant, H., & Sousa, A. D. (2021) · Springer eBooks · doi:10.1007/978-981-16-3864-0_22 · Cited by 1

Herbal Components for the Treatment of Alzheimer's Disease

Bisht, T., Sundram, S., Malviya, R., & Pandey, A. (2023) · The Natural Products Journal · doi:10.2174/2210315513666230123111541 · Cited by 1

Personalized behavioural psychotherapy and treatment for children with neurodegenerative disease using machine learning approaches

Patra, I., Sugumar, D., Yuvaraj, S. A., Bari, M. A., Nuhmani, S., & Unnisa, A. (2023) · AIP conference proceedings · doi:10.1063/5.0126160 · Cited by 1

Memantine in mild cognitive impairment and mild dementia of Alzheimer’s disease: theoretical background, clinical trials and recommendations

Sobów, T. (2014) · Aktualności Neurologiczne · doi:10.15557/an.2014.0006 · Cited by 1

Direct- And Spacer-Coupled Codrug Strategies for the Treatment of Alzheimer's Disease

Fornasari, E., Stefano, V. D., & Cacciatore, I. (2014) · Cited by 1

Development and validation of rapid and sensitive RP-HPLC method for estimation of memantine in tablets by using FMOC derivatization and UV-detection

Mokale, V. J. (2013) · Journal of Analytical & Bioanalytical Techniques · Cited by 1

Endogenous Kynurenic Acid and Neurotoxicity

Urbańska, E. M., Chmiel-Perzyńska, I., Perzyński, A., Derkacz, M., & Owe‐Larsson, B. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_92 · Cited by 1

Clinically Tolerated Strategies for NMDA Receptor Antagonism

Chen, H.-S. V., Zhang, D., & Lipton, S. A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-055-3_8 · Cited by 1

Multimodal Metabolomics Combining UPLC-qToF-MS and GC-MS Data in Plasma and Brain TissuePreprint

Ebshiana, A. A., Snowden, S. G., & Legido‐Quigley, C. (2017) · Preprints.org · doi:10.20944/preprints201704.0080.v1 · Cited by 1

Neurodegenerative Disease Diagnostics and Therapy of TiO 2 ‐Based Nanoparticles

Gao, X., Qin, J., Jiang, Z., Li, J., & Wu, A. (2020) · Wiley eBooks · doi:10.1002/9783527825431.ch7 · Cited by 1

Neuropharmacology

Wenk, G. L., & Marchalant, Y. (2009) · doi:10.1002/9780470478509.neubb001006 · Cited by 1

Participación de los receptores muscarínicos en el efecto del β - amiloide (25-35) sobre las neuronas piramidales de la región CA3 del hipocampo. Estudio Electrofisiológico

Castro, A. S. (2011) · Gredos (University of Salamanca) · doi:10.14201/gredos.110826

Effect of memantine in aging : the impact of hippocampal dependent memory

Pinho, J. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)

The influence of amyloid-beta, a major pathological marker in Alzheimer's disease, on molecular cognitive processes of APP+PS1 transgenic mice

Dickey, C. A. (2004) · Digital Commons - University of South Florida (University of South Florida)

Toxicidade induzida pelos peptídeos AB42 e AB25-35 em modelo de cultura organotípica de hipocampo de ratos

Nassif, M. (2006) · Americanae (AECID Library)

Treatment possibilities of Alzheimer's disease.

Miklya, I., & Gaszner, P. (2004) · PubMed

A review on treatment of Alzheimer’s disease

Pratihar, S., Nag, S., & Kundu, J. K. (2010) · Journal of Applied and Natural Science · doi:10.31018/jans.v2i1.115

Development of Radiotracers for Neuroimaging

Patel, N. (2015) · UCL Discovery (University College London)

Relationship between the adenosine A1 receptor and cGMP levels in the hippocampus: implications on neurotransmission and synaptic plasticity

Serpa, A. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)

The Effects of Melatonin with Memantin on MPTP-Induced Parkinson Model in Male Mice

Talebi, R., Alimoradian, A., & Sadegh, M. (2015) · DOAJ (DOAJ: Directory of Open Access Journals)

Alzheimer’s Disease Management: Current Therapy and Recent Drug Development

Abbasi, M., & Alam, M. R. (2016) · International Neuropsychiatric Disease Journal · doi:10.9734/indj/2016/24771

[3-[(1-Methylpiperidin-4-yl) methyl] arylsulfonyl]-1H-indoles: Synthesis, SAR and biological evaluation as a novel class of 5-HT6 Receptor Antagonists

Nirogi, R. V. S., Badange, R. K., Kandukuri, K. K., & Mukkanti, K. (2015) · Journal of Chemical Sciences · doi:10.1007/s12039-015-0800-7

Clinically Significant Interactions with Cholinesterase Inhibitors and Other Antidementia Agents

VanDenBerg, C. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-27883-4_22

Future Directions in Psychopharmacology of Autism Spectrum Disorder

Mankad, D., & Anagnostou, E. A. (2014) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814602167_0019

The influence of lysozyme and oligothiophenes on amyloid-β toxicity in models of Alzheimer’s disease

Sandin, L. (2016) · doi:10.3384/diss.diva-131797

Role of oxidative stress on acute ischaemic stroke

Setyopranoto, I. (2009) · Jurnal kedokteran dan kesehatan Indonesia · doi:10.20885/jkki.vol7.iss4.art6

Pharmacogenomics of Neurodegenerative Diseases: Roles in Personalized Medicines

Evande, R. E., Dutta, R., Tan, C., Grem, J. L., & Mahato, R. I. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_55

Proxy-PET Building Blocks as a Design Element for Library Synthesis

Mallin, L. J. (2015) · Journal of Bioresource Management

UNIVERSIDADE DO EXTREMO SUL CATARINENSE - UNESC CURSO DE PÓS-GRADUAÇÃO EM FARMACOLOGIA

Spillere, L. (2015)

Autophagy and apoptosis contribute to neuronal survival in a model system of oxytosis in vitro

Neunteibl, S. (2014) · open_UMR Marburg DSpace 10.0 (Philipps-Universität Marburg) · doi:10.17192/z2014.0463

Papel de receptores monoaminérgicos, colinérgicos e glutamatérgicos no efeito pro-mnéstico de Ptychopetalum olacoides Bentham (Olacaceae).

Saúde, B. D. (2006)

Molecular and Synaptic Alterations in the Striatum of GluN1-Deficient Mice

Chen, Y. (2018) · TSpace (University of Toronto)

Effects of Aβ42 on the human proteome and compound library screening using cellular models of Alzheimer's disease

Modak, S. (2013) · Research Explorer (The University of Manchester)

A cetamina associada ou não ao álcool, quais as consequências toxicológicas e sua influência no estresse oxidativo? Estudo em ratos

Mendes, P. F. (2019) · doi:10.11606/t.10.2019.tde-12122018-113556

Management of the predementia stage of Alzheimer’s disease, complicated with hypoactive delirium

Ткачева, О. Н., Cherdak, M. A., & Mkhitaryan, E. A. (2021) · Russian neurological Journal · doi:10.30629/2658-7947-2020-25-6-40-46

Elucidating the mechanisms of lipopolysaccharide-induced cognitive impairment in rats treated with tualang honey and its methanolic extraction

Yaacob, W. M. H. W. (2020) · Universiti Sains Malaysia Institutional Repository (Universiti Sains Malaysia)

Effect of coenzyme Q10 and/or epigallocatechin gallate on memantine-treated amnesia model in rats

Haleem, E. N. A. A., Ghafour, H. A. A. E., & Awdan, S. A. E. (2021) · Egyptian Pharmaceutical Journal · doi:10.4103/epj.epj_4_21

Búsqueda de agonistas LXR en plantas colombianas con potencial terapéutico para la enfermedad de Alzheimer

Rangel, B., & Milena, A. (2021)

Cognition

Hudkins, R. L., Marino, M. J., & Williams, M. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc242

Current awareness in human psychopharmacology

(2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.464

Memantine

Cada, D. J., Levien, T. L., & Baker, D. E. (2004) · Hospital Pharmacy · doi:10.1177/001857870403900311

Retina–brain axis and neuroprotection

Li, Y. M., Cheng, A. K., Manzar, H., Yap, T. E., & Cordeiro, M. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-819291-7.00023-x

Current awareness in geriatric psychiatry

(2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.794

Recent advancement in drugs of Alzheimer's disease

Zaidi, S. R., & Badola, A. (2022) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20223367

Lavender Essential oil Compounds as Antagonists of NMDA Receptor Subunit NR2B: A Molecular Modeling and Experimental Study

Ramezani, S., Shasaltaneh, M. D., & Khorie, M. M. A. (2022) · مجله علمی پزشکی جندی شاپور · doi:10.32598/jsmj.21.2.2257

Memantine and Glutamate Antagonists in the Treatment of Alzheimer's Disease: Current Updates

Kore, R., Tiwari, P., Patel, V. K., Shirbhate, E., Veerasamy, R., Mishra, A., & Rajak, H. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815136142123010008

Pharmacological interventions in dementia

Qazi, A., Kiss, I. M., Oyekan, S., & Parveen, S. (2019) · FPOP Bulletin Psychology of Older People · doi:10.53841/bpsfpop.2019.1.148.26

A Multidisciplinary Approach: Advancements in Regenerative Medicine and Biotechnology for CNS Repair

Markopoulos, H. K. (2025) · Journal of Biomedical Science and Engineering · doi:10.4236/jbise.2025.182002

Alzheimer's disease: Pharmacological approaches

ZEIDAN, H. M., & ZEIDAN, I. H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21632-9.00006-6

Bioequivalence of a Donepezil/Memantine 10/20 mg Fixed‐Dose Combination Versus Single‐Component Tablets in Healthy Korean Males

Choi, M., Jin, B. H., Keum, D. H., Mo, K. H., Park, M. S., Lee, J.-H., Park, S., & Kim, C. O. (2025) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.1556

Current Advancement of Enzymatic Targets for the Mitigation of Neurodegenerative Disorders

Dubey, S., & Abbas, N. (2025) · IGI Global eBooks · doi:10.4018/979-8-3373-4627-4.ch009

Computational Identification of Potent Multitarget Natural Ligands for Alzheimer’s Disease Therapeutics

Sharif, N., Bibi, A., Sadiq, R., Ullah, I., Rauf, A., Arshad, M. T., Bashir, S., Zamir, H., Gull, S., Anwar, T., et al. (2025) · Scientifica · doi:10.1155/sci5/1132636

Age-dependent alterations of TRPA1 and urocortin 1 signaling in the Edinger–Westphal nucleus in a mouse model of Alzheimer’s disease

Prókay, A. P., Konkoly, J., Kormos, V., Biró-Sütő, T., Kriszta, G., Szentmártoni, H. P., Berta, G., Gaszner, B., Zelena, D., & Pintér, E. (2026) · Scientific Reports · doi:10.1038/s41598-026-44022-5

Rôle de la dérégulation neuronale de la protéine kinase activée par l’AMP (AMPK) dans la pathologie tau, l’intégrité des synapses et le métabolisme énergétique : relevance pour la maladie d’Alzheimer

Domise, M. (2018) · theses.fr (ABES) · doi:10.70675/43c1f12fze623z41e8z970fz64a5de94a299

Conception et synthèse d’inhibiteurs duaux de DYRK1A et CLK1, kinases impliquées dans la maladie d’Alzheimer

Pescheteau, C. (2021) · theses.fr (ABES) · doi:10.70675/f258c770z5a4bz407bz9533z56a9b2b6a0f8

A Systematic Review on Disease‐Modifying Therapies in Parkinsonian Disorders

Eijsvogel, P. P. N. M., Smits, L. M. G., Kremer, P. H. C., & Groeneveld, G. J. (2026) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70315 · Cited by 1

Memantine as an Adjunctive Treatment for Residual Anxiety and Agitation in Early Parkinson's Disease With Depression: A Case Report

Haga, T., Mori, Y., Matsuda, N., Sato, A., Suzuki, Y., Ono, J., & Miura, I. (2026) · Neuropsychopharmacology Reports · doi:10.1002/npr2.70129

Therapeutic Targeting of the LXR Pathway for Improving Myelin Integrity in Neurodegeneration

Tamhankar, S. P., Singh, M., Xavier, J., Griffett, K., & Amin, R. (2026) · Cells · doi:10.3390/cells15211928

From pathogenesis to non-medical therapy: A review of exploring sensory and multi-sensory stimulation as a non-invasive treatment approach for Alzheimer’s disease

Zhu, Y., Jafari, Z., Kolb, B. E., & Mohajerani, M. H. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.107004

BindingDB Entry 50022848: Dizocilpine derivatives as neuroprotective NMDA receptor antagonists without psychomimetic side effects.

BindingDB (2026) · UC San Diego · doi:10.7270/q2dz0f5m

Neuroprotective and symptomatological action of memantine relevant for alzheimer’s disease — a unified glutamatergic hypothesis on the mechanism of action

Danysz, W., Parsons, C. G., Möbius, H. J., Stöffler, A., & Quack, G. (2000) · Neurotoxicity Research · doi:10.1007/bf03033787 · Cited by 262

Neuroprotective and symptomatological action of memantine relevant for Alzheimer’s disease e an unified glutamatergic hypothesis on the mechanism of action

Danysz, W., Parsons, C., Möbius, H., Stöffler, A., & Quack, G. (2000)

Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse

Parsons, C. G., Stöffler, A., & Danysz, W. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.07.013 · Cited by 724

NMDA receptor antagonists: Repositioning of memantine as a multitargeting agent for Alzheimer's therapy

(13455831), M. T. K., (15830342), M. S., (13455837), M. S. U., (13455840), M. M. B., (7724798), S. A., (9860528), A. I., (13377339), B. M., (13455843), M. S. I., (13455846), M. S. A., & (15815861), G. A. (2024) · Figshare · Cited by 2

Neuroprotección con memantina (antagonista no competitivo del receptor NMDA-glutamato) frente a la excitotoxicidad asociada al glutamato en la enfermedad de Alzheimer y en la demencia vascular

Tanovı́c, A., & Alfaro, V. (2006) · Revista de Neurología · doi:10.33588/rn.4210.2005252 · Cited by 32